These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Investigation of the mycobacterial enzyme HsaD as a potential novel target for anti-tubercular agents using a fragment-based drug design approach. Ryan A; Polycarpou E; Lack NA; Evangelopoulos D; Sieg C; Halman A; Bhakta S; Eleftheriadou O; McHugh TD; Keany S; Lowe ED; Ballet R; Abuhammad A; Jacobs WR; Ciulli A; Sim E Br J Pharmacol; 2017 Jul; 174(14):2209-2224. PubMed ID: 28380256 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological evaluation of nucleoside prodrugs designed to target siderophore biosynthesis in Mycobacterium tuberculosis. Dawadi S; Kawamura S; Rubenstein A; Remmel R; Aldrich CC Bioorg Med Chem; 2016 Mar; 24(6):1314-21. PubMed ID: 26875934 [TBL] [Abstract][Full Text] [Related]
4. Organocatalytic multicomponent reaction for the acquisition of a selective inhibitor of mPTPB, a virulence factor of tuberculosis. He R; Zeng LF; He Y; Wu L; Gunawan AM; Zhang ZY Chem Commun (Camb); 2013 Mar; 49(20):2064-6. PubMed ID: 23380872 [TBL] [Abstract][Full Text] [Related]
5. Unifying the Aminohexopyranose- and Peptidyl-Nucleoside Antibiotics: Implications for Antibiotic Design. Serrano CM; Kanna Reddy HR; Eiler D; Koch M; Tresco BIC; Barrows LR; VanderLinden RT; Testa CA; Sebahar PR; Looper RE Angew Chem Int Ed Engl; 2020 Jul; 59(28):11330-11333. PubMed ID: 32342623 [TBL] [Abstract][Full Text] [Related]
6. Investigation and conformational analysis of fluorinated nucleoside antibiotics targeting siderophore biosynthesis. Dawadi S; Viswanathan K; Boshoff HI; Barry CE; Aldrich CC J Org Chem; 2015 May; 80(10):4835-50. PubMed ID: 25916415 [TBL] [Abstract][Full Text] [Related]
7. O-Nucleoside, S-nucleoside, and N-nucleoside probes of lumazine synthase and riboflavin synthase. Talukdar A; Zhao Y; Lv W; Bacher A; Illarionov B; Fischer M; Cushman M J Org Chem; 2012 Jul; 77(14):6239-61. PubMed ID: 22780198 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of hypoxanthine guanine phosphoribosyltransferase by guanosine dialdehyde: an active site directed inhibitor. Johnson LA; Gordon RB; Emmerson BT Adv Exp Med Biol; 1979; 122B():87-91. PubMed ID: 546166 [No Abstract] [Full Text] [Related]
9. Pyrrolidine Compounds as Potential Lipid-Lowering Therapeutic in Cardiovascular Disease. Kargbo RB ACS Med Chem Lett; 2021 Apr; 12(4):521-523. PubMed ID: 33859785 [No Abstract] [Full Text] [Related]
10. Development of Prolinol Containing Inhibitors of Hypoxanthine-Guanine-Xanthine Phosphoribosyltransferase: Rational Structure-Based Drug Design. Keough DT; Petrová M; King G; Kratochvíl M; Pohl R; Doleželová E; Zíková A; Guddat LW; Rejman D J Med Chem; 2024 May; 67(9):7158-7175. PubMed ID: 38651522 [TBL] [Abstract][Full Text] [Related]
11. Untargeted Metabolomics of Feces Reveals Diagnostic and Prognostic Biomarkers for Active Tuberculosis and Latent Tuberculosis Infection: Potential Application for Precise and Non-Invasive Identification. Luo D; Yang BY; Qin K; Shi CY; Wei NS; Li H; Qin YX; Liu G; Qin XL; Chen SY; Guo XJ; Gan L; Xu RL; Dong BQ; Li J Infect Drug Resist; 2023; 16():6121-6138. PubMed ID: 37719654 [TBL] [Abstract][Full Text] [Related]
12. Hydroxy- and Amino-Phosphonates and -Bisphosphonates: Synthetic Methods and Their Biological Applications. Kaboudin B; Daliri P; Faghih S; Esfandiari H Front Chem; 2022; 10():890696. PubMed ID: 35721002 [TBL] [Abstract][Full Text] [Related]
13. Overview of Biologically Active Nucleoside Phosphonates. Groaz E; De Jonghe S Front Chem; 2020; 8():616863. PubMed ID: 33490040 [TBL] [Abstract][Full Text] [Related]
14. Pyrrolidine nucleoside bisphosphonates as antituberculosis agents targeting hypoxanthine-guanine phosphoribosyltransferase. Eng WS; Rejman D; Pohl R; West NP; Woods K; Naesens LMJ; Keough DT; Guddat LW Eur J Med Chem; 2018 Nov; 159():10-22. PubMed ID: 30265958 [TBL] [Abstract][Full Text] [Related]
15. First Crystal Structures of Mycobacterium tuberculosis 6-Oxopurine Phosphoribosyltransferase: Complexes with GMP and Pyrophosphate and with Acyclic Nucleoside Phosphonates Whose Prodrugs Have Antituberculosis Activity. Eng WS; Hocková D; Špaček P; Janeba Z; West NP; Woods K; Naesens LM; Keough DT; Guddat LW J Med Chem; 2015 Jun; 58(11):4822-38. PubMed ID: 25915781 [TBL] [Abstract][Full Text] [Related]